Single-dose cefotetan for urinary tract infection.
Seven female patients with lower urinary tract infection were treated with a single 2 g intramuscular dose of cefotetan. Six patients were clinically cured when seen 1 week after treatment and 5 patients remained well at 4 weeks after treatment. One patient developed loose stools and a vulval rash, 1 patient developed soreness and induration at the site of injection. There were no other side-effects.
D000293:Adolescent; D000328:Adult; D015313:Cefotetan; D002513:Cephamycins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests; D008837:Micrococcus / Q000187:drug effects; D008875:Middle Aged; D013212:Staphylococcus epidermidis / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D002513:Cephamycins; D015313:Cefotetan